Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1.

Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, van den Nieuwendijk R, van den Eeden SJ, Geluk A, Poot A, van der Marel G, Beijersbergen RL, Overkleeft H, Ottenhoff TH, Neefjes J.

Nature. 2007 Nov 29;450(7170):725-30.

PMID:
18046412
2.

Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators.

Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C.

Biochem J. 2008 Jan 15;409(2):449-59.

PMID:
17995453
3.

Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1.

Roach WG, Chavez JA, Mîinea CP, Lienhard GE.

Biochem J. 2007 Apr 15;403(2):353-8.

4.

Stress and mTORture signaling.

Reiling JH, Sabatini DM.

Oncogene. 2006 Oct 16;25(48):6373-83. Review.

PMID:
17041623
5.

Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.

Avruch J, Hara K, Lin Y, Liu M, Long X, Ortiz-Vega S, Yonezawa K.

Oncogene. 2006 Oct 16;25(48):6361-72. Review.

PMID:
17041622
6.

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

Ruvinsky I, Meyuhas O.

Trends Biochem Sci. 2006 Jun;31(6):342-8. Epub 2006 May 6. Review.

PMID:
16679021
7.

Regulation of protein synthesis by insulin.

Proud CG.

Biochem Soc Trans. 2006 Apr;34(Pt 2):213-6. Review.

PMID:
16545079
8.

Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein.

Eguez L, Lee A, Chavez JA, Miinea CP, Kane S, Lienhard GE, McGraw TE.

Cell Metab. 2005 Oct;2(4):263-72.

9.

Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking.

Larance M, Ramm G, Stöckli J, van Dam EM, Winata S, Wasinger V, Simpson F, Graham M, Junutula JR, Guilhaus M, James DE.

J Biol Chem. 2005 Nov 11;280(45):37803-13. Epub 2005 Sep 8.

10.

Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.

Jiang ZY, Zhou QL, Holik J, Patel S, Leszyk J, Coleman K, Chouinard M, Czech MP.

J Biol Chem. 2005 Jun 3;280(22):21622-8. Epub 2005 Mar 30.

11.

The expanding TOR signaling network.

Martin DE, Hall MN.

Curr Opin Cell Biol. 2005 Apr;17(2):158-66. Review.

PMID:
15780592
12.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Sarbassov DD, Guertin DA, Ali SM, Sabatini DM.

Science. 2005 Feb 18;307(5712):1098-101.

13.

mTOR, translational control and human disease.

Tee AR, Blenis J.

Semin Cell Dev Biol. 2005 Feb;16(1):29-37. Epub 2004 Dec 31. Review.

PMID:
15659337
14.

Novel insulin-elicited phosphoproteins in adipocytes.

Gridley S, Lane WS, Garner CW, Lienhard GE.

Cell Signal. 2005 Jan;17(1):59-66.

PMID:
15451025
15.

Upstream and downstream of mTOR.

Hay N, Sonenberg N.

Genes Dev. 2004 Aug 15;18(16):1926-45. Review.

16.

Advances in protein kinase B signalling: AKTion on multiple fronts.

Brazil DP, Yang ZZ, Hemmings BA.

Trends Biochem Sci. 2004 May;29(5):233-42. Review. No abstract available.

PMID:
15130559
17.

Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase C theta.

Burchfield JG, Lennard AJ, Narasimhan S, Hughes WE, Wasinger VC, Corthals GL, Okuda T, Kondoh H, Biden TJ, Schmitz-Peiffer C.

J Biol Chem. 2004 Apr 30;279(18):18623-32. Epub 2004 Feb 24.

18.

WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate.

Vitari AC, Deak M, Collins BJ, Morrice N, Prescott AR, Phelan A, Humphreys S, Alessi DR.

Biochem J. 2004 Feb 15;378(Pt 1):257-68.

19.

Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Luo J, Manning BD, Cantley LC.

Cancer Cell. 2003 Oct;4(4):257-62. Review. No abstract available.

20.
Items per page

Supplemental Content

Write to the Help Desk